These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1874602)

  • 21. Phase I trial of esorubicin (4'deoxydoxorubicin).
    Garewal HS; Robertone A; Salmon SE; Jones SE; Alberts DS; Brooks R
    J Clin Oncol; 1984 Sep; 2(9):1034-9. PubMed ID: 6470753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase 2 trial of pegylated liposomal doxorubicin in advanced endometrial cancer.
    Escobar PF; Markman M; Zanotti K; Webster K; Belinson J
    J Cancer Res Clin Oncol; 2003 Nov; 129(11):651-4. PubMed ID: 14505047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicenter experience of nonpegylated liposomal doxorubicin use in the management of metastatic breast cancer.
    Palmieri C; Misra V; Januszewski A; Yosef H; Ashford R; Keary I; Davidson N
    Clin Breast Cancer; 2014 Apr; 14(2):85-93. PubMed ID: 24325950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.
    Martino S; Samal BA; Redman B; Flaherty L; Kraut M; Simon M; Valdivieso M
    Breast Cancer Res Treat; 1990 Dec; 17(2):139-43. PubMed ID: 2096991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: a Gynecologic Oncology Group Study.
    Morrow CP; Bundy BN; Homesley HD; Creasman WT; Hornback NB; Kurman R; Thigpen JT
    Gynecol Oncol; 1990 Feb; 36(2):166-71. PubMed ID: 2298404
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liposome-encapsulated doxorubicin citrate in previously treated recurrent/metastatic gynecological malignancies.
    Angioli R; Palaia I; Calcagno M; Manci N; Zullo MA; Bellati F; Perniola G; de Vivo A; Benedetti Panici P
    Int J Gynecol Cancer; 2007; 17(1):88-93. PubMed ID: 17291237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II clinical evaluation of 4'-epi-doxorubicin.
    Hurteloup P; Cappelaere P; Armand JP; Mathé G
    Cancer Treat Rep; 1983 Apr; 67(4):337-41. PubMed ID: 6573956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Esorubicin in advanced ovarian epithelial cancer. A phase II study of the EORTC Gynecological Cancer Cooperative Group.
    van Oosterom AT; Aapro MS; Carnino F; van der Burg ME; Pecorelli S; Rotmensz N; Dalesio O; Vermorken JB
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1379-80. PubMed ID: 3181261
    [No Abstract]   [Full Text] [Related]  

  • 29. Phase II study of esorubicin in the treatment of patients with advanced sarcoma.
    Giaccone G; Donadio M; Calciati A
    Oncology; 1989; 46(5):285-7. PubMed ID: 2779944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Doxorubicin-cisplatin-vinblastine combination chemotherapy of advanced endometrial carcinoma: a Southwest Oncology Group Study.
    Alberts DS; Mason NL; O'Toole RV; Hilgers RD; Rivkin SE; Boutselis JG; Pugh RP; Vaitkevicius VK; Green JB; Oishi N
    Gynecol Oncol; 1987 Feb; 26(2):193-201. PubMed ID: 3542743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II clinical study of pirarubicin in hormone resistant prostate cancer.
    Rapoport BL; Falkson G
    Invest New Drugs; 1992 Jul; 10(2):119-21. PubMed ID: 1500266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized phase II study of acivicin and 4'deoxydoxorubicin in patients with hepatocellular carcinoma in an Eastern Cooperative Oncology Group study.
    Falkson G; Cnaan A; Simson IW; Dayal Y; Falkson H; Smith TJ; Haller DG
    Am J Clin Oncol; 1990 Dec; 13(6):510-5. PubMed ID: 2173394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase-II clinical trial of 4'-epi-doxorubicin in advanced solid tumors.
    Martoni A; Giovannini M; Tomasi L; Camaggi CM; Bellanova B; Monetti N; Rossini G; Tarquinii M; Martini A; Pannuti F
    Cancer Chemother Pharmacol; 1984; 12(3):179-82. PubMed ID: 6584236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II trial of adriamycin in the treatment of advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group study.
    Thigpen JT; Buchsbaum HJ; Mangan C; Blessing JA
    Cancer Treat Rep; 1979 Jan; 63(1):21-7. PubMed ID: 369691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of pegylated liposomal doxorubicin (Doxil) as second-line chemotherapy of squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Rose PG; Blessing JA; Lele S; Abulafia O
    Gynecol Oncol; 2006 Aug; 102(2):210-3. PubMed ID: 16478630
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phase II trial of esorubicin in advanced renal carcinoma. Clinical Screening Group of the EROTC.
    Hurteloup P; Chollet P; Roche H; Chevallier B; Cappelaere P; Van Glabbece M; Hayat M; Armand JP
    Eur J Cancer Clin Oncol; 1989 Jun; 25(6):995-6. PubMed ID: 2753061
    [No Abstract]   [Full Text] [Related]  

  • 37. Liposomal doxorubicin (Caelyx) in advanced pretreated soft tissue sarcomas: a phase II study of the Italian Sarcoma Group (ISG).
    Toma S; Tucci A; Villani G; Carteni G; Spadini N; Palumbo R
    Anticancer Res; 2000; 20(1B):485-91. PubMed ID: 10769710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II trial of biweekly pegylated liposomal doxorubicin in recurrent platinum-refractory ovarian and peritoneal cancer.
    Strauss HG; Hemsen A; Karbe I; Lautenschläger C; Persing M; Thomssen C
    Anticancer Drugs; 2008 Jun; 19(5):541-5. PubMed ID: 18418221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dexrazoxane. A review of its use as a cardioprotective agent in patients receiving anthracycline-based chemotherapy.
    Wiseman LR; Spencer CM
    Drugs; 1998 Sep; 56(3):385-403. PubMed ID: 9777314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carboplatin and nonpegylated liposomal doxorubicin in primary advanced or recurrent endometrial cancer: a phase 2 trial conducted by AGO Austria.
    Volgger B; Zeimet AG; Reinthaller A; Petru E; Schauer C; Klein M; Sevelda-Schwarzgruber U; Bogner G; Wolfram G; Marth C
    Int J Gynecol Cancer; 2015 Feb; 25(2):257-62. PubMed ID: 25611899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.